Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)

19.31
Delayed Data
As of Apr 20
 -0.17 / -0.87%
Today’s Change
13.15
Today|||52-Week Range
20.45
+0.36%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues210.5M251.5M255.2M240.2M
 
 
 
 
 
Cost of Goods Sold148.6M164.7M141.1M138.9M
 
 
 
 
 
Depreciation And Amortization14.4M13.3M14.6M15.4M
 
 
 
 
 
 
Operating ExpensesGross Income47.4M73.6M99.5M85.8M
 
 
 
 
 
General Expenses65.0M76.9M83.8M89.4M
 
 
 
 
 
Research And Development24.7M33.3M36.5M38.5M
 
 
 
 
 
Total Operating Expenses228.0M254.9M239.5M243.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-17.5M-3.4M15.7M-3.5M
 
 
 
 
 
Extraordinary Charge-439.0K-3.5M0.000.00
 
 
 
Interest Expense On Debt1.8M2.1M1.8M2.0M
 
 
 
 
 
Other Expenses201.0K-2.8M8.0K5.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-18.1M-10.4M14.9M1.6M
 
 
 
 
 
Income Taxes-7.4M-7.6M-4.4M-2.9M
 
 
 
 
 
Net Income-10.7M-2.8M10.5M4.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.0M45.0M45.4M46.1M
 
 
 
 
 
Shares To Calculate EPS Diluted42.0M45.0M47.5M48.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.25-$0.06$0.22$0.09
 
 
 
 
 
EPS Diluted-$0.25-$0.06$0.22$0.09